Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity-Score Matching Study and Meta-Analysis.

Zixu Zhao Chao JiangLiu HeShiyue ZhengYufeng WangMingyang GaoYi-Wei Lai Jingrui Zhang Mingxiao LiWenli DaiSong ZuoXueyuan GuoSong-Nan LiChenxi JiangNian LiuRi-Bo Tang De-Yong Long Xin DuCaihua SangChunguang Qiu Chang Sheng Ma

Published in: Journal of the American Heart Association (2023)

Our prospective study coupled with a meta-analysis demonstrated a lower risk of AF recurrence with the use of SGLT2i among patients with diabetes after AF ablation.

Keyphrases

atrial fibrillation
catheter ablation
left atrial
left atrial appendage
oral anticoagulants
direct oral anticoagulants
heart failure
percutaneous coronary intervention
venous thromboembolism
free survival
left ventricular
mitral valve